Completed

Phase 3
Age: 18Years - 75Years
All Genders
ID00000552

Led by Carelon Research · Updated on 2014-03-04

N/A

Participants Needed

N/A

Research Sites

N/A

Total Duration

On this page

Sponsors

C

Carelon Research

Lead Sponsor

N

National Heart, Lung, and Blood Institute (NHLBI)

Collaborating Sponsor

AI-Summary

What this Trial Is About

To test if early revascularization, primarily with angioplasty (PTCA) or bypass surgery (CABG), reduced all-cause in-hospital mortality from cardiogenic shock compared to conventional treatment, including thrombolysis.

CONDITIONS

Official Title

Shock Trial: Should We Emergently Revascularize Occluded Coronaries for Cardiogenic Shock.

Who Can Participate

Age: 18Years - 75Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

Men and women with myocardial infarction and cardiogenic shock.

Not Eligible

You will not qualify if you...

History of severe allergic reactions to study medication Currently pregnant or breastfeeding Recent participation in another clinical trial within the last 30 days Presence of uncontrolled medical conditions that could affect safety

Trial Site Locations

Site Locations not provided

Location information for this trial is currently unavailable.

How is the study designed?

Study Type

INTERVENTIONAL

Masking

N/A

Allocation

RANDOMIZED

Model

N/A

Primary Purpose

TREATMENT

Number of Arms

0

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here

Published Research Related To This Trial

Early revascularization in acute myocardial infarction complicated by cardiogenic shock. SHOCK Investigators. Should We Emergently Revascularize Occluded Coronaries for Cardiogenic Shock.

J S Hochman, L A Sleeper, J G Webb...

https://pubmed.ncbi.nlm.nih.gov/10460813

Outcome and profile of ventricular septal rupture with cardiogenic shock after myocardial infarction: a report from the SHOCK Trial Registry. SHould we emergently revascularize Occluded Coronaries in cardiogenic shocK?

V Menon, J G Webb, L D Hillis...

https://pubmed.ncbi.nlm.nih.gov/10985713

Cardiogenic shock due to acute severe mitral regurgitation complicating acute myocardial infarction: a report from the SHOCK Trial Registry. SHould we use emergently revascularize Occluded Coronaries in cardiogenic shocK?

C R Thompson, C E Buller, L A Sleeper...

https://pubmed.ncbi.nlm.nih.gov/10985712

Diabetes mellitus in cardiogenic shock complicating acute myocardial infarction: a report from the SHOCK Trial Registry. SHould we emergently revascularize Occluded Coronaries for cardiogenic shocK?

D M Shindler, S T Palmeri, T A Antonelli...

https://pubmed.ncbi.nlm.nih.gov/10985711

Cardiogenic shock with non-ST-segment elevation myocardial infarction: a report from the SHOCK Trial Registry. SHould we emergently revascularize Occluded coronaries for Cardiogenic shocK?

A K Jacobs, J K French, J Col...

https://pubmed.ncbi.nlm.nih.gov/10985710

SHould we emergently revascularize Occluded Coronaries for cardiogenic shocK: an international randomized trial of emergency PTCA/CABG-trial design. The SHOCK Trial Study Group.

J S Hochman, L A Sleeper, E Godfrey...

https://pubmed.ncbi.nlm.nih.gov/9924166

Angiographic findings and clinical correlates in patients with cardiogenic shock complicating acute myocardial infarction: a report from the SHOCK Trial Registry. SHould we emergently revascularize Occluded Coronaries for cardiogenic shocK?

S C Wong, T Sanborn, L A Sleeper...

https://pubmed.ncbi.nlm.nih.gov/10985708

Implications of the timing of onset of cardiogenic shock after acute myocardial infarction: a report from the SHOCK Trial Registry. SHould we emergently revascularize Occluded Coronaries for cardiogenic shocK?

J G Webb, L A Sleeper, C E Buller...

https://pubmed.ncbi.nlm.nih.gov/10985709

Cardiogenic shock due to cardiac free-wall rupture or tamponade after acute myocardial infarction: a report from the SHOCK Trial Registry. Should we emergently revascularize occluded coronaries for cardiogenic shock?

J Slater, R J Brown, T A Antonelli...

https://pubmed.ncbi.nlm.nih.gov/10985714